Preeclampsia
Preeclampsia is a pregnancy-specific multi-system disorder characterized by new-onset high blood pressure and often significant protein in the urine after 20 weeks of gestation, with potential complications including organ injury, severe hypertension, and increased risk of preterm labor. If untreated, it can lead to severe outcomes, including eclampsia, marked by seizures.
Health Outcomes
- Absence of Adverse Pregnancy Complications
- Altered Renal Profile
- Changed Maternal Plasma Fatty Acids
- Enhanced Trophoblast Invasion
- Improved Angiogenic Biomarker
- Improved Apgar Score at 1 Minute
- Improved Arginine to Asymmetric Dimethylarginine Ratio
- Improved Birth Weight
- Improved Endothelium-Dependent Vasodilation
- Improved Fetoplacental Circulation
- Improved Maternal Health
- Improved Perinatal Safety
- Improved Physiological Status in Offspring
- Improved Pregnancy Outcome
- Improved Safety in Pregnant Women
- Improved Uterine Artery Doppler Parameter
- Increased Blood Pressure
- Increased CSF3 Output in Placental Trophoblast Cells
- Increased Circulating Nitric Oxide Level
- Increased Endothelial Progenitor Cell Count
- Increased Folate Content
- Increased L-Arginine to ADMA Ratio
- Increased L-arginine Level
- Increased Leg Circumference
- Increased Maternal Weight Gain During Pregnancy
- Increased Neonatal Death
- Increased Nitrate Level
- Increased Nitric Oxide Level
- Increased PGDH Expression in Female Placentae
- Increased Plasma Serotonin Levels
- Increased Plasminogen Activator Inhibitor-1 Level
- Increased Systolic Blood Pressure
- Increased Total Body Water
- Increased VEGF Level
- Increased VEGF mRNA Level
- Influence on Infant Weight
- Modified Fetal Brain Metabolism
- Modulated Maternal Immune Response
- No Improvement in Adverse Pregnancy Outcomes
- No Significant Change in Blood Pressure
- Normal Pregnancy Outcomes
- Partially Reduced PTGS2 Levels in Male Placentas
- Prolonged Gestation
- Reduced Arginine Level
- Reduced Choline Level
- Reduced Edema
- Reduced Fetal Blood-Brain Barrier Dysfunction
- Reduced Fetal Complication
- Reduced Fetal Loss
- Reduced Folic Acid Level
- Reduced Gestational Age at Delivery
- Reduced HIF-1α Level
- Reduced Intrauterine Fetal Demise
- Reduced Intrauterine Growth Restriction
- Reduced Maternal Complication
- Reduced Maternal Death or Severe Morbidity
- Reduced Maternal Mortality
- Reduced Maternal and Neonatal Composite Outcome
- Reduced Maternal-Fetal Complications
- Reduced NICU Requirement
- Reduced Neonatal Complication
- Reduced Neonatal Death
- Reduced Neonatal Risk
- Reduced Perinatal Loss
- Reduced Perinatal Mortality
- Reduced Postpartum Hemorrhage Rate
- Reduced Pre-eclampsia or Pregnancy Loss
- Reduced Preeclampsia Risk
- Reduced Pregnancy Disorder Risk
- Reduced Preterm Birth
- Reduced Preterm Birth Rate
- Reduced Preterm Births
- Reduced Preterm Delivery
- Reduced Proteinuria
- Reduced Proteinuria Level
- Reduced Rate of Preterm Births Under 34 Weeks
- Reduced Risk of Infant Health Problems
- Reduced Risk of Preeclampsia
- Reduced Risk of Pregnancy Complications
- Reduced Risk of Severe Pre-eclampsia
- Reduced Risk of Small-for-Gestational-Age Birth
- Reduced Stillbirth
- Reduced Stillbirth or Fetal Death
- Reduced Urinary Nitrite Level
- Reduced Urinary Protein Level
- Reduced Vascular Endothelial Growth Factor
- Reduced Vascular Endothelial Growth Factor Level
- Safety During Pregnancy
- Shortened Labor Duration
- Successful Pregnancy Outcome
- Tolerability of Probiotics in Pregnancy